Trulicity in Iqaluit: Once-Weekly GLP-1 for Type 2 Diabetes by Video
Trulicity (dulaglutide) is a once-weekly injectable GLP-1 receptor agonist that Health Canada has approved to improve blood-sugar control in adults with Type 2 diabetes and to reduce the risk of major cardiovascular events. TelePlus Care connects Iqaluit patients with licensed doctors who assess your eligibility, review your bloodwork, and issue a prescription you fill at your local pharmacy — no flight south and no clinic queue. We serve residents across Nunavut's capital, from the Plateau and Apex to Lower Base and Tundra Valley.
Book Your Appointment Now
Trulicity (dulaglutide) is a once-weekly GLP-1 injection approved by Health Canada for Type 2 diabetes glycemic control and to lower cardiovascular risk in adults with the condition. It is not approved for weight loss. TelePlus Care provides virtual Iqaluit consultations with licensed doctors and issues prescriptions you fill at your local pharmacy.
- Trulicity is the brand name for dulaglutide, a once-weekly injectable GLP-1 receptor agonist.
- Health Canada has approved Trulicity for glycemic control in adults with Type 2 diabetes and to reduce the risk of major cardiovascular events in those with established cardiovascular disease or risk factors.
- Trulicity is given as a once-weekly subcutaneous injection using a single-use, pre-filled pen, which most Iqaluit patients self-administer at home.
- Trulicity is not a controlled substance, but it requires a prescription following a clinical assessment by a licensed doctor.
Clinical content is reviewed for accuracy and scope. TelePlus Care appointments proceed only when clinically appropriate after a real assessment, and the doctor will explain the next step if virtual care is not the right fit.
What Is Trulicity and How Does It Work?
Trulicity contains dulaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist. It mimics a natural gut hormone that prompts the pancreas to release insulin when blood sugar is high, slows stomach emptying, and reduces the glucose the liver produces. Together, these effects steady blood-sugar control through the day and lower HbA1c. Trulicity also carries a Health Canada indication to reduce the risk of major cardiovascular events in adults with Type 2 diabetes who have established cardiovascular disease or multiple risk factors. Some patients experience modest weight reduction as a secondary effect, but Trulicity is not approved in Canada for weight loss — it is prescribed to manage Type 2 diabetes. It is taken as a once-weekly injection that most Iqaluit patients give themselves at home.
Who Qualifies for Trulicity in Iqaluit?
Trulicity is for adults with Type 2 diabetes whose blood sugar is not adequately controlled by diet, exercise, and oral medications such as metformin. Your TelePlus Care doctor will review your history and current medications to decide whether Trulicity is appropriate.
- Adults with confirmed Type 2 diabetes seeking better glycemic control.
- Patients who have not reached their HbA1c target on metformin or other oral therapies.
- Adults with Type 2 diabetes plus established cardiovascular disease or risk factors who may benefit from cardiovascular risk reduction.
- Not for people with Type 1 diabetes or diabetic ketoacidosis.
- No personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
- No history of pancreatitis.
- Not currently pregnant or breastfeeding.
The Virtual Consultation Process at TelePlus Care
Iqaluit patients complete the entire assessment by video — no travel and no waiting on a fly-in doctor rotation. Each prescription is documented and shared with your care team at the local health centre on request. We don't dispense medication — we issue prescriptions you fill at your Iqaluit pharmacy.
- Step 1: Book online — most Iqaluit patients secure a same-day or next-business-day appointment.
- Step 2: Complete an intake form covering medical history, current diabetes medications, and recent HbA1c results.
- Step 3: Secure video consultation with your licensed doctor.
- Step 4: Bloodwork review or a new requisition arranged through Qikiqtani General Hospital lab services if your labs are out of date.
- Step 5: Prescription issued for your Iqaluit pharmacy, with guidance on the weekly injection routine.
- Step 6: Structured follow-ups to review blood-sugar response, side effects, and progress.
Required Bloodwork Before Starting Trulicity
Before starting a GLP-1 therapy for Type 2 diabetes, your doctor will want recent metabolic and organ-function labs. In Iqaluit, lab collection is handled through Qikiqtani General Hospital. Your doctor will arrange the requisition so your results are ready before you start.
- HbA1c — to confirm the diabetes diagnosis and establish a baseline for monitoring.
- Fasting plasma glucose.
- Kidney function — eGFR and serum creatinine.
- Liver enzymes — ALT and AST.
- Lipid profile — total cholesterol, LDL, HDL, triglycerides.
- TSH where thyroid screening is indicated.
- Pregnancy test for women of reproductive age where appropriate.
Side Effects of Trulicity
Trulicity shares the GLP-1 side-effect profile. Most effects are gastrointestinal, show up when the dose is first started or increased, and tend to ease over the following weeks. Taking the injection on the same day each week and starting at a low dose helps.
- Nausea — most common, especially in the first weeks.
- Diarrhea or constipation.
- Vomiting, particularly during a dose increase.
- Decreased appetite and indigestion.
- Injection site reactions — minor redness or itching.
- Hypoglycemia risk when combined with insulin or sulfonylureas.
- Rare: pancreatitis — severe abdominal pain radiating to the back; seek urgent care at Qikiqtani General Hospital's emergency department.
- Rare: gallbladder problems including gallstones.
- Rare: acute kidney injury linked to dehydration; maintain fluid intake.
access and next steps in Nunavut
Trulicity is a prescription medication you fill at a pharmacy, so the medication access is set by the pharmacy and your drug access, not by TelePlus Care. For our service, A licensed doctor reviews your intake before the visit and explains the safest next step.
- Your pharmacist can confirm medication-specific next steps.
- Non-Insured Health Benefits (NIHB) may support eligible diabetes medications for First Nations and Inuit clients; check your eligibility and the benefit list.
- Government of Nunavut employees and other groups may have employer or collective-agreement drug access.
- TelePlus Care consultation: Your intake helps the clinician understand your symptoms, history, and goals before the visit.
Why Iqaluit Patients Choose TelePlus Care for Trulicity
Access to consistent doctor care can be hard in the North, where many communities rely on health centres staffed by nurses with doctors flying in on rotation. TelePlus Care puts a licensed doctor on screen within minutes — no medevac, no flight south, and a clear booking process. Our doctors follow Diabetes Canada guidelines and prescribe Health Canada-approved diabetes therapies. We don't dispense medication — we issue prescriptions you fill at your Iqaluit pharmacy. Same-day virtual visits, clear appointment steps, and structured follow-ups are standard. If Trulicity is the right fit for your Type 2 diabetes, we can usually have you started promptly.
Your Fast and Convenient Healthcare Solution
Connect with a licensed healthcare provider from the comfort of your home. No referral needed — book your virtual appointment today.
Book Your Appointment Now
Teleplus care clinic is not an urgent care clinic. If you have an emergency please call911 or go to the nearest urgent care facility.
